T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea
· Delayed Price · Currency is KRW 2,900.00
-305.00 (-9.52%)
At close: Mar 9, 2026
T&R Biofab Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 5,472 | 16,672 | 20,228 |
| Short-Term Investments | 100 | - | 22,000 |
| Trading Asset Securities | - | 603.74 | 9,519 |
| Cash & Short-Term Investments | 5,572 | 17,276 | 51,747 |
| Cash Growth | -89.23% | -66.62% | - |
| Accounts Receivable | 3,221 | 2,251 | 1,476 |
| Other Receivables | - | 814.85 | 612.79 |
| Receivables | 3,221 | 3,066 | 2,088 |
| Inventory | 4,137 | 4,717 | 2,478 |
| Prepaid Expenses | - | 561.16 | 374 |
| Other Current Assets | 3,756 | 674.41 | 871.45 |
| Total Current Assets | 16,686 | 26,294 | 57,558 |
| Property, Plant & Equipment | 60,784 | 61,330 | 34,836 |
| Long-Term Investments | 907.36 | 2,285 | 2,996 |
| Other Intangible Assets | 929.87 | 978.48 | 831.24 |
| Long-Term Deferred Charges | 237.36 | 350.86 | - |
| Other Long-Term Assets | 4,313 | 7,215 | 3,595 |
| Total Assets | 83,857 | 98,453 | 99,816 |
| Accounts Payable | 1,503 | 503 | 13.31 |
| Accrued Expenses | - | 584.66 | 362.23 |
| Short-Term Debt | 21,477 | 22,468 | 28,299 |
| Current Portion of Leases | 888.8 | 752.09 | 1,019 |
| Current Unearned Revenue | - | - | 149.35 |
| Other Current Liabilities | 12,732 | 14,196 | 21,106 |
| Total Current Liabilities | 36,602 | 38,503 | 50,949 |
| Long-Term Debt | 22,650 | 22,490 | 16,200 |
| Long-Term Leases | 356.11 | 345.7 | 503.38 |
| Pension & Post-Retirement Benefits | 997.07 | 524.38 | - |
| Other Long-Term Liabilities | 8,995 | 10,035 | 966.07 |
| Total Liabilities | 69,600 | 71,899 | 68,619 |
| Common Stock | 10,773 | 10,773 | 10,762 |
| Additional Paid-In Capital | 148,340 | 145,367 | 145,327 |
| Retained Earnings | -153,702 | -138,331 | -130,518 |
| Comprehensive Income & Other | 5,894 | 6,401 | 5,627 |
| Total Common Equity | 11,305 | 24,211 | 31,197 |
| Shareholders' Equity | 14,257 | 26,554 | 31,197 |
| Total Liabilities & Equity | 83,857 | 98,453 | 99,816 |
| Total Debt | 45,373 | 46,056 | 46,021 |
| Net Cash (Debt) | -39,801 | -28,780 | 5,725 |
| Net Cash Per Share | -1539.90 | -1113.42 | 225.01 |
| Filing Date Shares Outstanding | 21.55 | 25.86 | 25.83 |
| Total Common Shares Outstanding | 21.55 | 25.86 | 25.83 |
| Working Capital | -19,916 | -12,209 | 6,609 |
| Book Value Per Share | 524.68 | 936.37 | 1207.85 |
| Tangible Book Value | 10,375 | 23,233 | 30,366 |
| Tangible Book Value Per Share | 481.52 | 898.53 | 1175.67 |
| Land | 24,290 | 24,290 | 9,745 |
| Buildings | 26,077 | 21,568 | 4,072 |
| Machinery | 7,911 | 20,378 | 4,535 |
| Construction In Progress | 982.07 | 5,706 | 17,476 |
Source: S&P Capital IQ. Standard template. Financial Sources.